Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122337) titled 'A Retrospective Study on Deep Learning-Based Dose Prediction for Nasopharyngeal Carcinoma Radiotherapy' on April 13.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The First Affiliated Hospital of China Medical University

Condition: Malignant tumor of nasopharynx.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-13

Target Sample Size: Nasopharyngeal malignant tumor observation group:150;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=318123

Published by HT Digital Content Services with perm...